Can innovation save the world’s broken healthcare system? This question will be before hundreds of chief executive officers, partners and top executives when they meet in San Francisco for the 2nd Annual Global Leaders Healthcare Forum on January 10, 2012.
The executives, from healthcare, biotech and pharmaceutical companies and their financial investment counterparts, represent 25 countries, 50 industries and 500 companies with revenues and assets exceeding $1 trillion. They’ll be probing an urgent proposition facing healthcare: can we bridge the gap between innovation and resources? One panel, moderated by Kathleen Sharp, a contributor to The New York Times and author of Blood Feud, will take a global view of healthcare and seek candid conclusions about world progress to date. The panel will grapple with a mixed picture, because, despite the enormous obstacles to providing affordable healthcare, on the horizon are remarkable breakthroughs; for example, new systems to help people keep track of all their own medical conditions.
Another panel will look at “Healthcare Regulatory Changes and the Impact on Innovation, Pricing and Reimbursement in Emerging Healthcare Companies.” It takes years to get a new drug approved and can cost upwards of $1 billion to deliver a new drug. What incentives, if any, does the FDA have to help get new treatments to the market? So often, it seems that the FDA pulls drugs off the market without complete explanation.
Other panels will look at efforts to speed up the drug approval process, how to provide incentives to help develop treatments, use of the tax structure to reward companies that take risk for the public good, and use of arbitration rather than litigation.
The Global Leaders is a digital community for CEOs and other senior-level executives in business, government, education and philanthropy.
A brochure with details about the forum is at: http://multivu.com/assets/53568/documents/The-Global-Leaders-2nd-Annual-Healthcare-Conference-V-original.pdf.
To register: http://tglhealthcaresymposium.eventbrite.com/.
Distinguished speakers at the forum will include: conference co-chair Dr. Margaret Liu, Vice Chairman, International Vaccine Institute; biotech and pharmaceutical pioneer Myrtle Potter, CEO of The Myrtle Potter Company; and Harry Kraemer, Executive Partner, Madison Dearborn. Evening activities include a reception and dinner sponsored by CTPartners and featuring speakers: Dr. Molly Coye, Chief Innovation Officer, UCL Health Systems; John Figueroa, CEO of Omnicare; and Mark Sirangelo, Chairman, Sierra Nevada Space Systems.
Lead sponsors include CTPartners, Epstein Becker & Green, and IDEA Pharma. Other sponsors are CorpShorts, PRNewswire/MultiVu, Robins, Kaplan, Miller & Ciresi, LLP, M.M. Dillon & Co., Elsevier Business Intelligence, M&A Chicago, AVG, LatinVision, The Conference Forum, One Mind for Research, Gershon Capital & Cie, Synergetics, Group 50 Consulting, Remerinc, International Vaccine Institute, and HSM Global.